Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Radiation Oncology/Therapy: Page 405
iCAD adds to coffers
By
AuntMinnie.com staff writers
Computer-aided detection (CAD) technology developer iCAD has a completed a private placement of its common stock, raising $8.4 million.
December 15, 2004
Ultralow-dose CT lung scan shows high accuracy at chest film dose
By
Eric Barnes
European researchers have been known to take low-dose CT exams to new levels of low, but a new study from Germany tests even continental norms. When researchers at Berlin's Charité Hospital cranked their thoracic CT exam down to the level of a two-view chest x-ray, they found the technique performed nearly as well as a standard CT exam in detecting pulmonary nodules.
December 12, 2004
ImaRx, Guerbet in MR molecular imaging deal
By
AuntMinnie.com staff writers
ImaRx Therapeutics and contrast media firm Guerbet of Roissy, France, have signed an agreement to jointly develop an MR contrast agent aimed at visualizing cancers at the molecular level.
December 9, 2004
Cardinal adds Primalert monitors
By
AuntMinnie.com staff writers
The Radiation Management Services division of Cardinal Health has debuted a line of Primalert digital area and doorway radiation monitors.
December 7, 2004
PET/CT hardware hybrid tops PET, software fusion for NSCLC staging
By
Jonathan S. Batchelor
Hardware-integrated PET/CT provides greater staging accuracy for non-small cell lung cancer (NSCLC) than either standalone PET imaging or software fusion of PET and CT images from nonintegrated modalities, according to research presented at the RSNA meeting in Chicago last week.
December 6, 2004
Lung cancer screening spots lesions early, gives patients additional longevity
By
Edward Susman
CT-based lung cancer screening can find the disease early enough to improve survival rates, especially in those patients who elect to have immediate surgery, according to the latest results from the International Early Lung Cancer Action Project (I-ELCAP).
December 5, 2004
Cervical cancer patients at small facilities receive less than optimal care
By
Shalmali Pal
In the U.S., screening for cervical cancer is standard and successful, but there are disparities with regard to cervical cancer treatment. Specifically, patients who undergo treatment at larger, more sophisticated facilities are more likely to receive better care, according to a study in the
International Journal of Radiation Oncology, Biology, Physics
.
December 5, 2004
MRI finds breast cancers missed by mammography in high-risk women
By
Peggy Peck
CHICAGO - Results of the International Breast MRI Consortium (IBMC) Trial reinforce previous studies that suggest MRI can identify breast tumors missed by mammography, but the IBMC results are not the final word on the MRI-mammography debate, according to a presentation at the RSNA meeting on Wednesday.
December 1, 2004
Small size no predictor of benign renal masses
By
Eric Barnes
CHICAGO - Renal masses are among the most common of incidental findings, and the increasing use of imaging in recent years has produced a fool's bounty of indeterminate lesions. Fortunately most are benign, and further evaluation is often reserved for masses 6 mm and larger.
December 1, 2004
Fischer cleared for interstitial breast brachytherapy
By
AuntMinnie.com staff writers
Fischer Imaging has received FDA clearance to use its MammoTest digital breast biopsy system for interstitial breast brachytherapy.
December 1, 2004
CT-guided RFA effective for local control and palliation of lung cancer
CHICAGO - Image-guided radiofrequency ablation (RFA) is a viable treatment option for lung cancer patients who are not good candidates for surgery, according to results from a series of 126 lung cancer patients treated with RFA.
November 30, 2004
GE and NCI collaborate on PET tracer
By
AuntMinnie.com staff writers
The Cancer Imaging Program of the National Cancer Institute (NCI) has submitted an investigational new drug application to the FDA for 18F-fluorothymidine (FLT).
November 30, 2004
Previous Page
Page 405 of 468
Next Page